Literature DB >> 25747350

Indirect purification method provides high yield and quality ssDNA sublibrary for potential aptamer selection.

Yinze Zhang1, Hua Xu2, Huayou Zhou3, Fan Wu4, Yuqin Su4, Yanlian Liang4, Dan Zhou4.   

Abstract

The quality and yield of single-stranded DNA (ssDNA) play key roles in ssDNA aptamer selection. However, current methods for generating and purifying ssDNA provides either low yield due to ssDNA loss during the gel purification process or low specificity due to tertiary structural damage of ssDNA by alkaline or exonuclease treatment in removing dsDNA and by-products. This study developed an indirect purification method that provides a high yield and quality ssDNA sublibrary. Symmetric PCR was applied to generate a sufficient template, while asymmetric PCR using an excessive nonbiotinylated forward primer and an insufficient biotinylated reverse primer combined with a biotin-strepavidin system was applied to eliminate dsDNA, hence, leading to ssDNA purification. However, no alkaline or exonuclease were involved in treating dsDNA, so as to warrant the tertiary structure of ssDNA for potential aptamer SELEX selection. Agarose gel imaging indicated that no dsDNA or by-product contamination was detected in the ssDNA sublibrary generated by the indirect purification method. Purified ssDNA concentration reached 1020±210nM, which was much greater than previous methods. In conclusion, this novel method provided a simple and fast tool for generating and purifying a high yield and quality ssDNA sublibrary.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aptamer; Asymmetric PCR; Biotin–streptavidin magnetic beads; Single-stranded DNA purification; Symmetric PCR

Mesh:

Substances:

Year:  2015        PMID: 25747350     DOI: 10.1016/j.ab.2015.02.027

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  2 in total

1.  Single-stranded DNA aptamer targeting and neutralization of anti-D alloantibody: a potential therapeutic strategy for haemolytic diseases caused by Rhesus alloantibody.

Authors:  Yinze Zhang; Fan Wu; Manni Wang; Naibao Zhuang; Huayou Zhou; Hua Xu
Journal:  Blood Transfus       Date:  2016-11-11       Impact factor: 3.443

Review 2.  Inside the Black Box: What Makes SELEX Better?

Authors:  Natalia Komarova; Alexander Kuznetsov
Journal:  Molecules       Date:  2019-10-07       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.